Back
Structure Therapeutics Quote, Financials, Valuation and Earnings
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
36
GPCR
Structure Therapeutics
Last Price:
39.29
Seasonality Move:
-35.87%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Structure Therapeutics Price Quote
$39.29
-0.01 (-1.13%)
(Updated: November 6, 2024 at 5:12 AM ET)
Structure Therapeutics Key Stats
Sell
36
Structure Therapeutics (GPCR)
is a Sell
Day range:
$38.33 - $40.53
52-week range:
$26.61 - $72.16
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.44%
Volume:
516.4K
Avg. volume:
679.9K
1-year change:
-43.76%
Market cap:
$2.2B
Revenue:
$0
EPS:
$-2.22
How Much Does Structure Therapeutics Make?
Data Unavailable
Is Structure Therapeutics Growing As A Company?
Data Unavailable
Structure Therapeutics Stock Price Performance
-
Did Structure Therapeutics Stock Go Up Last Month?
Structure Therapeutics share price went down by -8.58% last month -
Did GPCR's Share Price Rise Over The Last Year?
GPCR share price fell by -43.76% over the past 1 year
What Is Structure Therapeutics 52-Week High & Low?
-
What Is Structure Therapeutics’s 52-Week High Share Price?
Structure Therapeutics has traded as high as $72.16 over the past 52 weeks -
What Is Structure Therapeutics’s 52-Week Low Share Price?
Structure Therapeutics has traded as low as $26.61 over the past 52 weeks
Structure Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Structure Therapeutics?
-
How Much Debt Does Structure Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Structure Therapeutics Have?
Cash and short term investments quarterly total is $927.1M -
What Is Structure Therapeutics’s Book Value Per Share?
Book value per share is 16.10
Is Structure Therapeutics Cash Flow Positive?
-
What Is GPCR Cash Flow From Operations?
Cash flow from operations (TTM) is -$102.8M -
What Is Structure Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $797.5M -
What Is Structure Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$353.7M
Structure Therapeutics Return On Invested Capital
Data Unavailable
Structure Therapeutics Earnings Date & Stock Price
-
What Is Structure Therapeutics's Stock Price Today?
A single share of GPCR can be purchased today for 39.30 -
What Is Structure Therapeutics’s Stock Symbol?
Structure Therapeutics trades on the nasdaq under the ticker symbol: GPCR -
When Is Structure Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Structure Therapeutics is scheduled on November 14, 2024 -
When Is GPCR's next ex-dividend date?
Structure Therapeutics's next ex-dividend date is November 6, 2024 -
How To Buy Structure Therapeutics Stock?
You can buy Structure Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Structure Therapeutics Competitors
-
Who Are Structure Therapeutics's Competitors?
Below is a list of companies who compete with Structure Therapeutics or are related in some way:
Structure Therapeutics Dividend Yield
-
What Is GPCR Dividend Yield?
Structure Therapeutics’s dividend yield currently is 0% -
What Is Structure Therapeutics’s Payout Ratio?
Structure Therapeutics’s payout ratio is 0% -
When Did Structure Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Structure Therapeutics’s Dividend Per Share?
Structure Therapeutics pays a dividend of $0.00 per share
Structure Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 20% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 86.50 |
| Upside from Last Price: | 120.1% |